
Leo Pharma has announced in a press release that its emission reduction targets have been validated by the Science Based Targets initiative (SBTi), which is a collaboration between the World Resources Institute, UN Global Compact and the World Wide Fund (WWF) and more.
”Emission reduction targets are considered science-based if they are in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement – to limit global warming to well-below 2 degrees Celsius above pre-industrial levels and pursue efforts to limit warming to 1.5 degrees Celsius,” the statement reads.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app